Electrophysiologists at the Austin-based Texas Cardiac Arrhythmia Institute at St. David’s Medical Center are the first in the nation to implant a new defibrillation lead.
The FDA-approved device is a specialized, insulated wire that connects to an implantable cardioverter-defibrillator or cardiac resynchronization therapy device to correct abnormal rhythm, according to a Jan. 30 system news release. The new device is the world’s smallest, catheter-delivered defibrillation lead.
The first procedure was performed by Robert Canby, MD, and Amin Al-Ahmad, MD, on Jan. 7.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
